Bayer investor has cost the Acquisition of the seed group at Monsanto, many billions. However, in the balance sheet of the purchase of the controversial US-based company reflected the first positive. The sales skyrocketed to the top.
sales surged 42.4 percent to 13 billion euros, as the Dax group announced in Leverkusen, Germany. – So exchange rate effects, as well as purchases and sales of company parts removed could Bayer to grow by 4.1 percent.
adjusted for special effects earnings before interest, taxes, depreciation and amortization (Ebitda) rose by 44.6 per cent to nearly 4.2 billion euros. Both indicators, the average of analysts ‘ estimates estimates.
Strong agri-business
The good Figures is due to Bayer, especially strong growth in the agricultural business, the 63-billion dollar Monsanto acquisition had been extended last summer. At the same time the power of the glyphosate does not break down complaints because of the alleged carcinogenic effect of the Monsanto-developed herbicide: in the Meantime, Bayer in the United States with around 13,400 plaintiffs faced. Finally, there were more than 11.200.
A farmer of the plant protection product glyphosate on a field from
In the agricultural business benefited Bayer mainly from the growth in Latin and North America. In the pharmaceutical division of the anticoagulant Xarelto and the eye drug Eylea strong back wind that is delivered once more, while the division for non-prescription medicines (Consumer Health) recorded a slight decline in sales and a significant profit decline.
operating profit of € 12.2 billion expected to be
the bottom line is that Leverkusen deserved due to costs for the ongoing restructuring of the group, as well as in connection with the Monsanto purchase with 1.24 billion Euro 36.5 percent less than a year ago. The year Outlook was confirmed.
For the full year, the group expects a currency – and portfolio-adjusted sales increase of about four percent to about 46 billion euros and a rise in adjusted operating profit to 12.2 billion.
for More price information of the Bayer group
